Biolegend, 422801, DAPI (4',6-Diamidino-2-Phenylindole, Dilactate), 10mg

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate), a blue fluorescent nucleic acid stain, preferentially binds dsDNA and associates with the minor groove AT clusters. The molecular weight for DAPI is 457.5.  Association of DAPI with dsDNA increases fluorescence approximately 20-fold, with an emission maximum of 460 nm. The increase in fluorescence is believed to be due to displacement of water molecules from the minor groove and DAPI. DAPI can also bind RNA and emits at a longer wavelength of 500 nm, with only a 20% increase in fluorescence. DAPI is a popular nuclear stain for identification of cell cycle and specifically stains nuclei but not cytoplasm. The dilactate form is more water soluble compared to the dihydrochloride form. DAPI can be excited by a UV laser, xenon, or a mercury-arc lamp.
10mg
Formulation: Lyophilized
Preparation: To make 5 mg/ml (10.9 mM) solution, dissolve entire contents of vial in 2 ml of deionized water.
Storage & Handling: Store between 2°C and 8°C, protected from light. For long term storage, aliquot and store at -20°C.
Application: ICFC, ICC
Recommended Usage: This product can be used at 30 µM for flow cytometry and 300 nM for immunofluorescence. It is recommended to titrate the dye for optimal performance.
Excitation Laser: Ultraviolet Laser (355 nm)
Application Notes: Protocols for Counterstaining with DAPI: Immunofluorescence Staining Note: Cells may be fixed by method of choice, such as with 4% paraformaldehyde. DAPI staining is done after staining for other markers. Fixation and permeabilization of cells is not necessary to counterstain with DAPI. 1. Fix cells using method of choice. 2. Incubate the cells with phosphate buffered saline (PBS) for 15 minutes. 3. Dilute the DAPI solution (we recommend to 300 nM) with PBS. Remove excess PBS from the slide and cover with DAPI solution, making sure the cells are completely covered. 4. Incubate for up to 5 minutes. Rinse the slide several times to remove all free DAPI. It is recommended to use a mounting medium with antifade reagent to reduce fluorescence quenching. The slide is ready to view under the microscope with appropriate filters. Nuclear Staining for Flow Cytometry Note: Cells may be fixed with 4% paraformadehyde or absolute ethanol. 1. Fix cells with absolute ethanol or 4% paraformaldehyde. 2. Centrifuge, discard the supernatant, and add 5 ml of PBS, allowing cells to rehydrate for 15 minutes. 3. Dilute the DAPI to 30 µM (recommended) in staining buffer (such as BioLegend's FOXP3 Perm Buffer, Cat. No. 421402). 4. Centrifuge cell suspension from step 3 above, discard supernatant, and add 1 ml of DAPI solution; then incubate at room temperature for 15 minutes. 5. Analyze by flow cytometry using an instrument with appropriate lasers.
Additional Product Notes: View more applications data for this product in our Scientific Poster Library.
Application References(PubMed link indicates BioLegend citation): Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed Sodhi CP, et al. 2015. J Immunol. 194:4931. PubMed
Product Citations: Sierro F, et al. 2017. Immunity. 47:374. PubMed Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed Cherkaoui S, et al. 2022. Mol Syst Biol. 18:e11033. PubMed Chang L, et al. 2023. Life Sci Alliance. 6:. PubMed Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed Flinn MA, et al. 2023. Front Cardiovasc Med. 10:1142612. PubMed Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed Huber M, et al. 2023. Nat Commun. 14:2143. PubMed Kerkering J, et al. 2023. J Clin Invest. . PubMed Basta MD, et al. 2023. iScience. 26:106570. PubMed Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed Gómez-Pinedo U, et al. 2023. Cells. 12:. PubMed Hoover MY, et al. 2023. Nat Protoc. . PubMed Davila ML, et al. 2022. iScience. 25:104426. PubMed DeDreu J, et al. 2021. Matrix Biol. 96:18. PubMed Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed McCubbrey AL, et al. 2022. Cell Rep. 38:110222. PubMed Xiang J, et al. 2022. J Virol. 96:e0005722. PubMed Matta B, et al. 2022. Front Immunol. 13:951254. PubMed Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed Reemst K, et al. 2022. Transl Psychiatry. 12:507. PubMed Kaneko K, et al. 2022. Cancers (Basel). 14: . PubMed Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed Sountoulidis A, et al. 2023. Nat Cell Biol. 25:351. PubMed Wang CQ, et al. 2023. Cells. 12: . PubMed Jeon EY, et al. 2023. Bioeng Transl Med. 8:e10362. PubMed Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed Aru B, et al. 2023. Balkan Med J. 40:117. PubMed González-Terán B, et al. 2022. Cell. 185:794. PubMed Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed Wu N, et al. 2020. Cell Rep. 30:1129. PubMed Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed Gabriely G, et al. 2021. iScience. 24:103347. PubMed Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed Kobayashi T, et al. 2019. Cell. 176:982. PubMed Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed Nguyen DT, et al. 2022. Cells. 11:. PubMed Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed Ambrosi TH, et al. 2021. Elife. 10: . PubMed DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed Koh P, et al. 2016. Sci Data. 3:160109. PubMed Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed Wu CL, et al. 2021. Nat Commun. 12:362. PubMed Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed Teo YV, et al. 2019. Cell Rep. 27:997. PubMed Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed Pagan JD, et al. 2018. Cell. 172:564. PubMed Zhang X, et al. 2022. JCI Insight. 7:. PubMed Zhu M, et al. 2021. Eneuro. 8:. PubMed Flores-Pliego A, et al. 2021. Cells. 10:. PubMed Shani O, et al. 2021. Elife. 10: . PubMed Moser J, et al. 2016. Sci Rep. 6:35387. PubMed Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed Lehrke MJ, et al. 2021. Elife. 10:. PubMed Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed Kissiov DU, et al. 2022. Elife. 11:. PubMed Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed Phan TS, et al. 2021. Sci Adv. 7:. PubMed Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed Anisul M, et al. 2021. Elife. 10:. PubMed DeDreu J, et al. 2022. FASEB J. 36:e21995. PubMed Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed Chen HY, et al. 2020. J Immunol. 1158:204. PubMed Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed Tominaga K, et al. 2022. iScience. 25:103667. PubMed
Biology Area: Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Antigen References: 1. Langlois RG, et al. 1980. Chromosoma. 77:229. 2. Kubista M, et al. 1987. Biochemistry 26:4545.
Gene ID: NA
Regulatory Status: RUO
Other Names: 4',6-Diamidino-2-Phenylindole, Dilactate